Back
Clearside Biomedical 10K Form
Sell
31
CLSD
Clearside Biomedical
Last Price:
1.11
Seasonality Move:
22.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLSD News And Ratings
See the #1 stock for the next 7 days that we like better than CLSD
CLSD Financial Statistics
Sales & Book Value
| Annual Sales: | $8.23M |
|---|---|
| Cash Flow: | $-6.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.38 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.50000 |
|---|---|
| Net Income (TTM): | $-33.46M |
| Gross Margin: | $7.87M |
| Return on Equity: | 0% |
| Return on Assets: | -92.06% |
Clearside Biomedical Earnings Forecast
Key Clearside Biomedical Financial Ratios
- The Gross Profit Margin over the past 5 years for CLSD is 95.68%.
- The Selling, General & Administrative Expenses for CLSD have been equal to 144.29% of Gross Profit Margin.
- The Research & Development expenses have been 253.42% of Revenue.
- The Interest Expense is -28.81% of Operating Income.
- The Net Earning history of CLSD is -394.91% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 4 years.
Clearside Biomedical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CLSD |
| CUSIP: | 185063 |
| Website: | clearsidebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.07 |
| Quick Ratio: | 5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLSD Technical Analysis vs Fundamental Analysis
Sell
31
Clearside Biomedical (CLSD)
is a Sell
Is Clearside Biomedical a Buy or a Sell?
-
Clearside Biomedical stock is rated a Sell
The current Clearside Biomedical [CLSD] share price is $1.09. The Score for CLSD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.